InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: BluE33 post# 22961

Saturday, 09/19/2020 4:28:48 PM

Saturday, September 19, 2020 4:28:48 PM

Post# of 198610
Oh yeah, I'm thinking the same thing. A lot of breadcrumbs out there indicating that this will be a Mega Merger with several entities (and all of their assets and IP) getting rolled up under the $ENZC umbrella.

This new structure works to achieve economies of scale and it also makes sense to do a Mega Merger because there are synergies between each of the company's IP, research efforts, and direct connections between team members.

They've all been working towards a cure for many years and read each other's findings, know where the money flows (e.g., CEPI, Davos, and Gates Foundation), etc.

Its worth noting that our Duke PHD (Dr. Montefiore) received $32M from the Gates Foundation for HIV research in 2017 so the DIRECT connection is there.

The price action and dollar volume at these levels indicate big players are buying up massive blocks of shares and will be willing to wait for the results. This ain't a day trade for them.

Flippers and impatient investors are going to be sick when all of the catalysts hit.

This is a biotech with real potential in final stages of society shifting treatments in a space that covers $30.5 BILLION DOLLAR MARKET.

We've seen stocks like this (even lesser biotech stocks such as phase 1 or phase 2 completion) go to dollars real quick.

With Covid on everyone's mind and an HIV treatment proven to be 95% effective without harsh toxic side effects, there's no reason this can't run into dollars especially if 1 or 2 hedge funds get on board.

Weekends are time to catch up on research for a lot of people and the fact that this is still sub-penny is going to draw some monster whales to the party to continue to pick up massive blocks of shares.